Potassium Channel Blockers

All categories
DBCAT000519Therapeutic category

A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. A DrugBank category of 9 drugs. 6 of them are approved.

Also known as
Blockers, Potassium Channel · Channel Blockers, Potassium · Potassium Channel Antagonists
Drugs

What you can answer from here — as of March 13, 2021

9DrugsEach linked to its full drug card
Listed above
46Drug targetsEvery drug–target pair in the class, with bond type
Sign in
1,311Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
5Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Potassium Channel Blockers share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In